Marisol S. Castaneto

1.5k total citations · 1 hit paper
22 papers, 1.1k citations indexed

About

Marisol S. Castaneto is a scholar working on Toxicology, Pharmacology and Molecular Biology. According to data from OpenAlex, Marisol S. Castaneto has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Toxicology, 15 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Marisol S. Castaneto's work include Forensic Toxicology and Drug Analysis (17 papers), Cannabis and Cannabinoid Research (11 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Marisol S. Castaneto is often cited by papers focused on Forensic Toxicology and Drug Analysis (17 papers), Cannabis and Cannabinoid Research (11 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Marisol S. Castaneto collaborates with scholars based in United States, Sweden and Germany. Marisol S. Castaneto's co-authors include Marilyn A. Huestis, Nathalie A. Desrosiers, David A. Gorelick, Rebecca L. Hartman, Sandrine Pirard, Ariane Wohlfarth, Robert Kronstrand, Karl B. Scheidweiler, Mingshe Zhu and Shaokun Pang and has published in prestigious journals such as Journal of Chromatography A, Clinical Chemistry and Analytical and Bioanalytical Chemistry.

In The Last Decade

Marisol S. Castaneto

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

2014 485 citations Marisol S. Castaneto, David A. Gorelick et al. Drug and Alcohol Dependence profile →

Peers

Countries citing papers authored by Marisol S. Castaneto

Since Specialization

Citations

This map shows the geographic impact of Marisol S. Castaneto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisol S. Castaneto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisol S. Castaneto more than expected).

Fields of papers citing papers by Marisol S. Castaneto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisol S. Castaneto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisol S. Castaneto. The network helps show where Marisol S. Castaneto may publish in the future.

Co-authorship network of co-authors of Marisol S. Castaneto

This figure shows the co-authorship network connecting the top 25 collaborators of Marisol S. Castaneto. A scholar is included among the top collaborators of Marisol S. Castaneto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisol S. Castaneto. Marisol S. Castaneto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Updated Adult Human Red Blood Cell Acetylcholinesterase Activity Reference Range with Time-Modified Michel Method 2024 ·Clinical Chemistry ·(unknown), (unknown), Marisol S. Castaneto, (unknown), (unknown), Matthew D. Wegner, (unknown)	2
2	Human red blood cell acetylcholinesterase activity: a revisit after fifteen years 2024 ·Drug and Chemical Toxicology ·(unknown), (unknown), Marisol S. Castaneto, (unknown), (unknown), (unknown), (unknown), Matthew D. Wegner, (unknown)	0
3	A Hidden Gem: Highlighting the Indispensable Capabilities and History of the DoD Cholinesterase Monitoring Program and DoD Cholinesterase Reference Laboratory 2023 ·Military Medicine ·(unknown), (unknown), (unknown), Marisol S. Castaneto, Matthew D. Wegner, (unknown)	1
4	Impact of cannabis‐infused edibles on public safety and regulation 2022 ·Journal of Forensic Sciences ·(unknown), (unknown), Marisol S. Castaneto	4
5	Metabolic profiling of synthetic cannabinoid 5F‐ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra‐high‐performance liquid chromatography/high‐resolution mass spectrometry 2020 ·Rapid Communications in Mass Spectrometry ·Brandon C. Presley, Marisol S. Castaneto, Barry K. Logan, (unknown)	15
6	Can synthetic urine replace authentic urine to “beat” workplace drug testing? 2018 ·Drug Testing and Analysis ·(unknown), (unknown), (unknown), (unknown), (unknown), Marisol S. Castaneto	15
7	Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography–high resolution mass spectrometry and library matching 2015 ·Journal of Chromatography A ·Marta Concheiro, Marisol S. Castaneto, Robert Kronstrand, Marilyn A. Huestis	94
8	Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA 2015 ·The AAPS Journal ·Ariane Wohlfarth, Marisol S. Castaneto, Mingshe Zhu, Shaokun Pang, Karl B. Scheidweiler, Robert Kronstrand, Marilyn A. Huestis	94
9	Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testing 2015 ·Analytical and Bioanalytical Chemistry ·Marisol S. Castaneto, Allan J. Barnes, Marta Concheiro, K. L. Klette, (unknown), Marilyn A. Huestis	21
10	Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography–Mass Spectrometry 2015 ·Therapeutic Drug Monitoring ·Dīlek Battal, Allan J. Barnes, Marisol S. Castaneto, Thomas M. Martin, K. L. Klette, Marilyn A. Huestis	4
11	Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices 2015 ·Drug Metabolism Reviews ·Marisol S. Castaneto, Ariane Wohlfarth, Nathalie A. Desrosiers, Rebecca L. Hartman, David A. Gorelick, Marilyn A. Huestis	93
12	Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry 2015 ·Forensic Toxicology ·Marisol S. Castaneto, Ariane Wohlfarth, Shaokun Pang, Mingshe Zhu, Karl B. Scheidweiler, Robert Kronstrand, Marilyn A. Huestis	61
13	Metabolic characterization of AH‐7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation 2015 ·Drug Testing and Analysis ·Ariane Wohlfarth, Karl B. Scheidweiler, Shaokun Pang, Mingshe Zhu, Marisol S. Castaneto, Robert Kronstrand, Marilyn A. Huestis	32
14	Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications breakdown → 2014 ·Drug and Alcohol Dependence ·Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers, Rebecca L. Hartman, Sandrine Pirard, Marilyn A. Huestis	485
15	Method Validation of The Biochip Array Technology for Synthetic Cannabinoids Detection in Urine 2014 ·Bioanalysis ·Marisol S. Castaneto, Nathalie A. Desrosiers, Kayla N. Ellefsen, Sébastien Anizan, Thomas M. Martin, K. L. Klette, Marilyn A. Huestis	15
16	Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology 2014 ·Drug Testing and Analysis ·Kayla N. Ellefsen, Sébastien Anizan, Marisol S. Castaneto, Nathalie A. Desrosiers, Thomas M. Martin, K. L. Klette, Marilyn A. Huestis	45
17	Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens 2014 ·Drug Testing and Analysis ·Marisol S. Castaneto, Karl B. Scheidweiler, Adarsh Gandhi, Ariane Wohlfarth, K. L. Klette, Thomas M. Martin, Marilyn A. Huestis	35
18	Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens 2014 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Ariane Wohlfarth, Karl B. Scheidweiler, Marisol S. Castaneto, Adarsh Gandhi, Nathalie A. Desrosiers, K. L. Klette, Thomas M. Martin, Marilyn A. Huestis	29
19	Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids 2014 ·Drug Testing and Analysis ·(unknown), Allan J. Barnes, (unknown), Marisol S. Castaneto, Thomas M. Martin, K. L. Klette, Marilyn A. Huestis	25
20	Identifying Methamphetamine Exposure in Children 2013 ·Therapeutic Drug Monitoring ·Marisol S. Castaneto, Allan J. Barnes, Karl B. Scheidweiler, Michael Schäffer, Kristen Rogers, (unknown), Marilyn A. Huestis	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact